![Parastoo Khoshakhlagh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Parastoo Khoshakhlagh
Amministratore Delegato presso GC Therapeutics, Inc.
Provenienza dei contatti di primo grado di Parastoo Khoshakhlagh
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
GC Therapeutics, Inc.
![]() GC Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services GC Therapeutics, Inc. is a company based in Cambridge, MA. GC Therapeutics uses synthetic biology to program stem cells into any cell type with efficiency, speed, and scalability. The company has validated cells for many applications and have developed supercells™ by tailoring cells for specific diseases. The company's goal is to bring this breakthrough approach to patients. The company was founded in 2019 by Parastoo Khoshakhlagh, Alex Ng, Cory Smith, and George McDonald Church, with Parastoo Khoshakhlagh as the CEO since 2019.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Tympanogen, Inc.
![]() Tympanogen, Inc. Medical SpecialtiesHealth Technology Tympanogen, Inc. develops innovative devices for the ear, nose, and throat. The company is based in Richmond, VA. The company was founded in 2014 by Parastoo Khoshakhlagh, Jesse Ranney, Elaine Horn-Ranney. Elaine Horn-Ranney has been the CEO since 2014.
3
| Holding Company | Medical Specialties | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Parastoo Khoshakhlagh tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
Stanford University | College/University | Doctorate Degree | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
Virginia Commonwealth University | College/University | Undergraduate Degree | |
The Virginia Biotechnology Research Park
![]() The Virginia Biotechnology Research Park Real Estate DevelopmentFinance The Virginia Biotechnology Research Park operates a pharmaceutical and biotechnology corridor. The private company is based in Richmond, VA. Chandra Briggman has been the CEO of the company since 2020. | Real Estate Development | Chief Executive Officer | |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Virginia Biotechnology Research Partnership Authority | Local Agencies | Director/Board Member | |
BiVACOR, Inc.
![]() BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX. | Medical Specialties | Director/Board Member | |
Richmond 2015
![]() Richmond 2015 Movies/EntertainmentConsumer Services Richmond 2015 is a non-profit company that conducts and promotes cycle and bike race competitions. The company is based in Richmond, VA. | Movies/Entertainment | Director/Board Member | |
The Virginia Bioscience Foundation | Director/Board Member | ||
Expansion Therapeutics, Inc.
![]() Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Pharmaceuticals: Major | Director/Board Member | |
Cormorant Asset Management LLC/Private Equity/
![]() Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Arkuda Therapeutics, Inc.
![]() Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Startup Virginia, Inc.
![]() Startup Virginia, Inc. Miscellaneous Commercial ServicesCommercial Services Startup Virginia, Inc. is a non profit organization that helps entrepreneurs of high-growth startups reach its full potential. It also provides entrepreneurial guidance and education with support from its partners, mentors, investors, and donors. The company was founded by Brad Cummings, Karen Booth Adams, Will Loving, Jay Sanne, and Bryan Bostic in 2016 and is headquartered in Richmond, VA. | Miscellaneous Commercial Services | Director/Board Member | |
ONK Therapeutics Ltd.
![]() ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Biotechnology | Director/Board Member | |
Garuda Therapeutics, Inc.
![]() Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
Chamberrva | Director/Board Member | ||
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 18 |
Irlanda | 2 |
Settori
Health Technology | 7 |
Consumer Services | 5 |
Finance | 4 |
Commercial Services | 3 |
Government | 2 |
Posizioni
Director/Board Member | 17 |
Founder | 4 |
Chief Executive Officer | 2 |
Undergraduate Degree | 2 |
Corporate Officer/Principal | 2 |
Contatti più connessi
Insiders | |
---|---|
Raymond Kelleher | 11 |
Carrie Roth | 9 |
Elaine Horn-Ranney | 2 |
Alex Ng | 1 |
Cory Smith | 1 |
Brett Losen | 1 |
Jesse Ranney | 1 |
- Borsa valori
- Insiders
- Parastoo Khoshakhlagh
- Connessioni Società